Theralase Technologies Inc. (CVE:TLT – Get Free Report)’s stock price traded up 10.2% during mid-day trading on Tuesday . The stock traded as high as C$0.28 and last traded at C$0.27. 223,000 shares were traded during mid-day trading, an increase of 115% from the average session volume of 103,522 shares. The stock had previously closed at C$0.25.
Theralase Technologies Trading Up 14.3 %
The company has a current ratio of 1.21, a quick ratio of 3.40 and a debt-to-equity ratio of 20.58. The company has a market cap of C$68.75 million, a PE ratio of -14.00 and a beta of 1.36. The stock has a 50 day moving average price of C$0.27 and a 200 day moving average price of C$0.23.
About Theralase Technologies
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Read More
- Five stocks we like better than Theralase Technologies
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Stock Average Calculator
- What Does the Future Hold for Eli Lilly?
- Investing in Travel Stocks Benefits
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
